Cleared Special

K083340 - LEVITRONIX CENTRIMAG PRIMARY CONSOLE

Also marketed or referenced as:
THORATEC CANTRIMAG PRIMARY CONSOLE

K083340 is an FDA 510(k) clearance for LEVITRONIX CENTRIMAG PRIMARY CONSOLE, manufactured by Levitronix, LLC. The device is a Class 2 Cardiovascular device with product code DWA cleared through the Special 510(k) pathway after a 14-day FDA review.

K083340 · Levitronix, LLC · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2008
Decision
14d
Days
Class 2
Risk

K083340 is an FDA 510(k) clearance for the LEVITRONIX CENTRIMAG PRIMARY CONSOLE. Classified as Control, Pump Speed, Cardiopulmonary Bypass (product code DWA), Class II - Special Controls.

Submitted by Levitronix, LLC (Waltham, US). The FDA issued a Cleared decision on November 26, 2008 after a review of 14 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.4380 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Levitronix, LLC devices

FDA 510(k) Submission Details - K083340

510(k) Number K083340 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 12, 2008
Decision Date November 26, 2008
Days to Decision 14 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
111d faster than avg
Panel avg: 125d · This submission: 14d
Pathway characteristics
Modification to existing cleared device.

DWA Device Classification - Class 2, Special Controls

Product Code DWA Control, Pump Speed, Cardiopulmonary Bypass
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.4380
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DWA Control, Pump Speed, Cardiopulmonary Bypass

All 20
Devices cleared under the same product code (DWA) and FDA review panel - the closest regulatory comparables to K083340.
SORIN CENTRIFUGAL PUMP 5 (CP5)
K112225 · Sorin Group Deutschland GmbH · Sep 2011
STOCKERT CENTRIFUGAL PUMP (SCP PLUS) (COMPLETE) OR (FOR S5/C5 SYSTEMS)
K103468 · Sorin Group Deutschland GmbH · Jan 2011
STOCKERT CENTRIFUGAL PUMP PLUS SYSTEM (SCP PLUS), MODELS 60-00-10, 60-00-55
K091008 · Sorin Group Deutschland GmbH · Jul 2009
BIO-CONSOLE 560
K080824 · Medtronic Perfusion Systems · May 2008
BIO-CONSOLE, MODEL 560
K070286 · Medtronic · May 2007
TANDEM HEART ESCORT (T.H.E.) CONTROLLER, MODEL 5140-8500
K061369 · Cardiacassist, Inc. · Aug 2006